Skip to content
Research Article Open access CC BY 4.0

Discriminating Benign and Malignant Brain Tumors By Spectral Analysis of Cerebrospinal Fluid

V. Masilamani, R. Vidhya Shree, Ajay T. Prasad, Kannan Ramamurthy, Chellappan Selvaraju, Wafa Mohammed Alsaleh, Tahani A. Alrebdi, Trinka Vijmasi, A. Thiruvalluvan, V. Chandramouleeswaran

Journal of Pharmaceutical Research International · pp. 37–48 · Published 2 Sep 2022

10.9734/jpri/2022/v34i49A36425

Abstract

The preliminary study is concerned with an innovative technique for the discrimination of malignant brain tumor from benign with reasonable sensitivity and specificity. The entire study is based on the relative fluorescence intensity and life-time of bio-fluorophores like tryptophan and tyrosine which are then validated as a set of ratio parameters. Resultantly, it was seen that malignancy was characterized by three-fold enhancement of tyrosine. The picosecond-time resolved decay time measurement was done, which exhibited two-fold decrease in decay time for malignant sample. The improved accessibility, with minimal invasiveness to the patient, and lower cost are encouraging aspects of this technique.

Cerebrospinal fluid (CSF) fluorescence spectra time resolved spectra malignant brain tumor benign brain tumor

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

16

Page views

0

PDF downloads

2

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.